| PDF (695kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-91786
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.9178
Zusammenfassung
In 24 patients with cutaneous T-cell lymphomas (CTCL) the clinical course was documented by determination of a tumour burden index (TBI) on entering the study and six months later. In addition to the first TBI, soluble interleukin-2 receptor levels (slL-2R) in the serum were determined using an ELISA technique in 23 patients. In 18 patients natural killer cell (NK) activity was assessed by a 4 h ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags